The Koch Institute brings interdisciplinary approaches together to advance the fight against cancer.
More places to follow us: http://bit.ly/m/mitkochinstitute
MIT Koch Institute
Loading...
Congratulations to Robert Langer — 2026 recipient of the Robert A. Welch Award in Chemistry! His groundbreaking work on controlled drug release and tissue engineering has shaped medicine worldwide. welch1.org/awards/welch-award-in-chemistry
There's still time to register for #KIAS2026: Diet & Metabolism in Cancer, this Thursday, June 18!
Session 2 - Diet-gut interactions in cancer - features Omer Yilmaz (MIT) and Wendy Garrett (Harvard/Dana-Farber). Don't miss it! buff.ly/oUD9uBe
How do nutrition & metabolism influence cancer? That’s one of the central questions at the 2026 Koch Institute Annual Symposium. On 6/18, leading experts will come together to explore this topic & highlight new insights that can advance cancer prevention & treatment.
Register: mit-ki.org/4tv7Br9
How does chromatin move inside the nucleus?
Researchers in the Hansen Lab identified two distinct movement patterns — rapid local motion and slower long-range motion — that may help shape interactions between genes and regulatory elements.
buff.ly/32HBaaZ
Just days left to register for #KIAS2026: Diet & Metabolism in Cancer, this Thursday, June 18! Session 1, Influence of diet on health and cancer, features Walter Willett, Mandar Muzumdar, and Matt Vander Heiden. Secure your spot now: mit-ki.org/4tv7Br9
Daniel Anderson, Robert Langer, and former postdoc Omid Veiseh have launched Duracyte, bringing implantable “living drug factories” one step closer to the clinic.
mit-ki.org/4x9vZS4
Don’t miss the 2026 Koch Institute Annual Symposium on 6/18! This day-long symposium features leading experts discussing how nutritional & metabolic factors shape cancer development & therapy& spark interdisciplinary discussion to advance cancer prevention & treatment. Register: mit-ki.org/4tv7Br9
Registration is open for the 2026 Koch Institute Symposium! On 6/18, experts will explore how nutritional & metabolic factors influence cancer development & therapy foster interdisciplinary discussions & highlight insights that can advance cancer prevention & treatment Register: mit-ki.org/4tv7Br9
Missed Inside INLEXZO on April 29? The recording is now live.
Michael Cima and Karen Daniel, PhD ’09, take you inside INLEXZO™—a newly FDA-approved therapy for muscle-invasive bladder cancer—and the pretzel-shaped platform behind it.
Watch the video:
www.youtube.com/watch?v=fEt8...
Congrats to @jcstark.bsky.social on being named a 2026 Pershing Square Sohn Cancer Prize awardee, supporting bold, high-risk ideas w/ potential to transform cancer research. Her work explores how cancer-cell glycans can be harnessed for new approaches to precision immunotherapy. mit-ki.org/42kmCAX
MIT Koch Institute
MIT Koch Institute
MIT Koch Institute
MIT Koch Institute
MIT Koch Institute
MIT Koch Institute
MIT Koch Institute
MIT Koch Institute
MIT Koch Institute
MIT Koch Institute
Learn the origin story behind the development and recent FDA approval of INLEXZO™, a new treatment for muscle invasive bladder cancer, and the pretzel-shaped drug delivery platform behind it.…
